Martine Rothblatt's Common Stock Sales in United Therapeutics Corp

Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp, has filed a notice of sale of common stock. The filing details the sale of 4,000 shares on October 21, 2025, with an aggregate market value of $1,711,042.80. Additionally, the filing reports multiple sales of common stock over the past three months, totaling 116,000 shares with gross proceeds exceeding $19 million. The securities were sold through TD Securities (USA) LLC. The shares were acquired on March 15, 2016, as part of an Executive Deferred Compensation plan. The filing indicates no gifts were involved in these transactions.